A 42 year old patient with bilateral loss of sight and hypertension;42-Jähriger patient mit bilateralem visusverlust und hypertensiver entgleisung

Internist

Volumn 49, Issue 8, 2008, Pages 989-994

  Schmidt, A ^a   Schwella, N ^a   Helmchen, U ^b   Von Renteln, D ^a   Caca, K ^a  

^a KLINIKUM LUDWIGSBURG   (Germany)

^b UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

Gemcitabine; Hemolytic uremic syndrome; Loss of vision; Thombotic microangiopathy

Indexed keywords

AMLODIPINE; CISPLATIN; CLONIDINE; DIHYDRALAZINE; DOXORUBICIN; ETOPOSIDE; FUROSEMIDE; GEMCITABINE; PREDNISOLONE; RAMIPRIL;

ACUTE KIDNEY FAILURE; ADRENAL CORTEX CARCINOMA; ADULT; ARTICLE; CASE REPORT; COMBINATION CHEMOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; HEMOLYTIC ANEMIA; HEMOLYTIC UREMIC SYNDROME; HISTOPATHOLOGY; HUMAN; HYPERTENSION; MALE; MONOTHERAPY; THROMBOCYTOPENIA; THROMBOTIC THROMBOCYTOPENIC PURPURA; TREATMENT OUTCOME; VISUAL IMPAIRMENT;

ADRENAL CORTEX NEOPLASMS; ADULT; ANEMIA, HEMOLYTIC; ANTIMETABOLITES, ANTINEOPLASTIC; BIOPSY; BLINDNESS; DEOXYCYTIDINE; DIAGNOSIS, DIFFERENTIAL; HEMOLYTIC-UREMIC SYNDROME; HUMANS; HYPERTENSION, MALIGNANT; KIDNEY; MALE; PURPURA, THROMBOTIC THROMBOCYTOPENIC;

EID: 48849112395     PISSN: 00209554     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00108-008-2123-y     Document Type: Article

References (25)

1. Berns JS, Kaplan BS, Mackow RC, Hefter LG (1992) Inherited hemolytic uremic syndrome in adults. Am J Kidney Dis 19: 331-334
2. Biecker E, Schwarze C, Ko YD, Sauerbruch T (2001) Nierenversagen, Thrombozytopenie und hämolytische Anämie bei einem 36-jährigen Patienten. Internist 24: 1031-1034
3. Cattell V (1985) Mitomycin-induced hemolytic uremic kidney. A experimental model in the rat. Am J Pathol 121: 88-95
4. Dlott JS, Danielson CF, Blue-Hnidy DE, McCarthy LJ (2004) Drug-induced thrombotic thrombocytopenic purpura / hemolytic uremic syndrome: A concise review. Ther Apher Dial 8: 102-111
5. Dundas S, Murphy J, Soutar RL et al. (1999) Effectiveness of therapeutic plasma exchange in the 1996 Lanarkshire E. coli O157:H7 outbreak. Lancet 354: 1327-1330
6. Eknoyan G, Riggs SA (1986) Renal involvement in thrombotic thrombocytopenic purpura. Am J Nephrol 6: 117
7. Flombaum CD, Mouradian JA, Casper ES et al. (1999) Thrombotic microangiopathy as a complication of long-term therapy with gemcitabine. Am J Kidney Dis 33: 555-562
8. Furlan M, Robles R, Galbusera M et al. (2002) von Willebrand factor cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome. N Engl J Med 339: 1578
9. George JN (2000) How I treat patients with thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Blood 96: 1223-1229
10. George JN (2006) Clinical practice. Thrombotic thrombocytopenic purpura. N Engl J Med 354: 1927-1935
11. Habib R, Gagnadoux MF, Broyer M (1981) Hemolytic uremic syndrome in children and arterial hypertension. Arch Mal Coeur Vaiss 74: 37-43
12. Hovinga JA, Studt JD, Alberio L, Lammle B (2004) von Willebrand factor cleaving protease (ADAMTS-13) activitiy determination in the diagnosis of thrombotic microangiopathies: the Swiss experience. Semin Hematol 41: 75-82
13. Howard MA, Wiliams LA, Terrell DR et al. (2006). Complications of plasma exchange in patients treated for clinically suspected thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Transfusion 46: 154-156
14. Humphreys, BD, Sharman JP, Henderson JM et al. (2004) Gemcitabine-associated thrombotic microangiopathy. Cancer 100: 2664-2670
15. Jimenez JJ, Jy W, Mauro LM et al. (2003) Endothelial microparticles in thrombotic thrombocytopenic purpura express von Willebrand factor and markers of endothelial activation. Br J Haematol 123: 896
16. Köster M, Wege T, Ganzemüller C, Lengfelder W (2001) 44-jährige Patientin mit Trombozytopenie, Multiorganversagen und disseminierter intravasaler Gerinnung. Internist 42: 905-909
17. Noris M, Remuzzi G (2005) Hemolytic uremic syndrome. J Am Soc Nephrol 16: 1035-1050
18. Remuzzi G (1987) HUS and TTP: Variable expression of a single entity. Kidney Int 32: 292
19. Rock GA, Shumak KH, Buskard NA et al. (1991) Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. N Engl J Med 325: 393-397
20. Rose BD, George JN (2005) Causes of thrombocytopenic purpura-hemolytic uremic syndrome in adults. http://www.uptpdate.com
21. Rose BD, George JN (2005) Diagnosis of thrombotic thrombocytopenic purpura-hemolytic uremic syndrome in adults. http://www.uptpdate.com
22. Saif MW, McGee PJ (2004) Hemolytic-uremic syndrome associated with gemcitabine: a case report and review of literature. JOP 6: 369-374
23. Tsai HM, Lian E (1998) Antibodies to von Willebrand factor-cleaving protease in thrombotic microangiopathies: a study of 11 cases. N Engl J Med 339: 1585-1594
24. Veyradier A, Obert B, Houllier A et al. (2001) Specific von Willebrand factor cleaving protease (ADAMTS13) is deficiant in recurrent and familial thrombotic thrombocytopenic purpura and hemolytic uremic syndrome. Blood 98: 1765-1772
25. Zupancic M, Prabodh CS, Shah-Kan F (2007) Gemcitabine-associated thrombocytopenic purpura. Lancet Oncol 8: 634-641